Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose

Gene Therapy

Volumn 10, Issue 9, 2003, Pages 774-780

  Haberkorn, U ^a,b   Kinscherf, R ^a   Kissel, M ^b   Kubler W ^b   Mahmut, M ^b   Sieger, S ^b   Eisenhut, M ^b   Peschke, P ^b   Atlmann, A ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Gene therapy; Human sodium iodide transporter; Prostate carcinoma

Indexed keywords

HYGROMYCIN; IODINE 131; MULTIDRUG RESISTANCE PROTEIN; RETROVIRUS VECTOR; SODIUM IODIDE; SODIUM IODIDE SYMPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CARCINOMA CELL; CELL LEVEL; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; CULTURE MEDIUM; DNA MODIFICATION; DOSIMETRY; DRUG ABSORPTION; DRUG ACCUMULATION; GENE DOSAGE; GENE THERAPY; GENETIC ASSOCIATION; GENETIC TRANSDUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; RADIOACTIVITY; RAT; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ABSORPTION; ADENOCARCINOMA; ANIMALS; BIOLOGICAL TRANSPORT; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; IODIDES; IODINE RADIOISOTOPES; MALE; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS; RATS; RATS, INBRED STRAINS; RETROVIRIDAE; SYMPORTERS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0037766148     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301943     Document Type: Article

References (38)

1. Marcocci C, Cohen JL, Grollman EF. Effect of actinomycin D on iodide transport in FRL-5 thyroid cells. Endocrinology 1984; 115: 2123-2132.
2. Weiss SJ, Philp NJ, Grollman EF. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 1984; 114: 1090-1098.
3. Paire A, Bernier-Valentin F, Selmi-Ruby S, Rousset B. Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. J Biol Chem 1997; 272: 18245-18249.
4. Nakamura Y, Ohtaki S, Yamazaki I. Molecular mechanism of iodide transport by thyroid plasmalemmal vesicles: cooperative sodium activation and asymmetrical affinities for the ions on the outside and inside of the vesicles. J Biochem 1988; 104: 544-549.
5. Nakamura Y, Kotani T, Ohtaki S. Transcellular ioide transport and iodination on the apical plasma membrane by monolayer porcine thyroid cells cultured on collagen-coated fibers. J Endocrinol 1990; 126: 275-281.
6. Smanik PA et al. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 1996; 226: 339-345.
7. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379: 458-460.
8. Boland A et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000; 60: 3484-3492.
9. Boland A et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Thyroid 2002; 12: 19-26.
10. Carlin S et al. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two- and three-dimensional models. Cancer Gene Ther 2000; 7: 1529-1536.
11. - symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 2000; 7: 740-749.
12. Haberkorn U et al. Transfer of the human sodium iodide symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001; 42: 317-325.
13. La Perle KMD et al. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer. Prostate 2002; 50: 170-178.
14. Mandell RB, Mandell LZ, Link CJ. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999; 59: 661-668.
15. - symporters for radioiodide concentrator gene therapy. J Nucl Med 2000; 41: 1898-1904.
16. - symporter gene. Endocrinology 1997; 138: 4493-4496.
17. Smit JW et al. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line. Thyroid 2000; 10: 939-943.
18. 131I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line. J Clin Endocrinol Metab 2002; 87: 1247-1253.
19. Spitzweg C et al. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 2000; 60: 6526-6530.
20. Spitzweg C et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 2001; 8: 1524-1531.
21. Huang M et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 2001; 8: 612-618.
22. Berman M, Hoff E, Barandes M. Iodine kinetics in man: a model. J Clin Endocrinol Metab 1968; 28: 1-14.
23. Freireich EJ et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Rep 1966; 50: 219-244.
24. Maxon HR et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983; 309: 937-941.
25. Haberkorn U et al. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene. Eur J Nucl Med 2001; 28: 633-638.
26. 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab 1999; 84: 912-916.
27. Urabe M et al. Effect of lithium on function and growth of thyroid cells in vitro. Endocrinology 1991; 129: 807-814.
28. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998; 8: 909-913.
29. 131I in thyroid gland of man and rat. Life Sci 1968; 7: 1257-1264.
30. Temple R, Berman M, Robbins J, Wolff J. The use of lithium in the treatment of thyrotoxicosis. J Clin Invest 1972; 51: 2746-2756.
31. Gershengorn MC, Izumi M, Robbins J. Use of lithium as an adjunct to radioiodine therapy of thyroid carcinoma. J Clin Endocrinol Metab 1976; 42: 105-111.
32. Sieger S et al. Tumour specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3). Eur J Nucl Med: in press.
33. Dadachova E et al. Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Nucl Med Biol 2002; 29: 13-18.
34. Petrich T et al. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium iodide symporter. Eur J Nucl Med 2002; 29: 842-854.
35. Haberkorn U, Altmann A, Eisenhut M. Functional genomics and proteomics - the role of nuclear medicine. Eur J Nucl Med 2002; 29: 115-132.
36. Pear WS, Nolan GP, Scott ML, Baltimorre D. Production of high titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.
37. Kinscherf R et al. Induction of manganese superoxide dismutase by oxidized-LDL - its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 1997b; 11: 1317-1328.
38. Stabin M. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538-546.